# The Efficacy of Sequential RT After Triple Therapy for uHCC

> **NCT07052448** · — · ENROLLING_BY_INVITATION · sponsor: **Fujian Provincial Hospital** · enrollment: 35 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** sequential radiotherapy after the combination of transcatheter arterial chemoembolization (TACE) combined with lenvatinib and anti-PD-1 antibodies

## Key facts

- **NCT ID:** NCT07052448
- **Lead sponsor:** Fujian Provincial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2020-11-01
- **Primary completion:** 2026-06-01
- **Final completion:** 2026-06-30
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2025-07-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07052448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07052448, "The Efficacy of Sequential RT After Triple Therapy for uHCC". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07052448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*